JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 10 09 2020
accepted: 10 12 2020
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 22 6 2021
Statut: epublish

Résumé

c-Jun N-terminal protein kinase 1 (JNK1) is involved in multiple biological processes but its implication in inflammatory skin diseases is still poorly defined. Herein, we studied the role of JNK1 in the context of Aldara

Identifiants

pubmed: 33613525
doi: 10.3389/fimmu.2020.604785
pmc: PMC7892463
doi:

Substances chimiques

Cytokines 0
Inflammation Mediators 0
EGFR protein, mouse EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Mitogen-Activated Protein Kinase 8 EC 2.7.11.24
Imiquimod P1QW714R7M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

604785

Informations de copyright

Copyright © 2021 Le, Azouz, Thomas, Istaces, Nguyen and Goriely.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Otol Neurotol. 2019 Jun;40(5):584-594
pubmed: 31083077
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14114-9
pubmed: 15375216
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6028-33
pubmed: 20231445
Br J Dermatol. 2006 Jul;155(1):213-4
pubmed: 16792781
Nat Commun. 2013;4:1560
pubmed: 23463003
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13451-6
pubmed: 16938889
Clin Exp Dermatol. 2014 Jun;39(4):461-7
pubmed: 24825137
Dev Cell. 2003 Jun;4(6):879-89
pubmed: 12791272
Science. 2013 Jan 11;339(6116):218-22
pubmed: 23223452
Sci Immunol. 2019 Nov 29;4(41):
pubmed: 31784499
J Leukoc Biol. 2009 Apr;85(4):673-83
pubmed: 19164127
World J Gastroenterol. 2015 Mar 28;21(12):3746-9
pubmed: 25834345
Microbiol Mol Biol Rev. 2016 Jul 27;80(3):793-835
pubmed: 27466283
J Am Acad Dermatol. 2012 Jun;66(6):e251-3
pubmed: 22583734
J Invest Dermatol. 2014 Jul;134(7):1912-1921
pubmed: 24569709
Nat Commun. 2016 Dec 16;7:13581
pubmed: 27982014
Clin Transl Med. 2016 Dec;5(1):36
pubmed: 27590145
Arch Dermatol Res. 2003 Jul;295(3):93-101
pubmed: 12768307
Blood. 2006 Feb 1;107(3):1078-84
pubmed: 16219795
JAMA Dermatol. 2013 Oct;149(10):1173-9
pubmed: 23925466
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10723-8
pubmed: 23754427
J Am Acad Dermatol. 2009 Apr;60(4):643-59
pubmed: 19217694
J Invest Dermatol. 2011 Feb;131(2):329-37
pubmed: 20962853
Arthritis Rheum. 2011 Jun;63(6):1603-12
pubmed: 21305529
Genes Cancer. 2013 Sep;4(9-10):409-13
pubmed: 24349639
Am J Transl Res. 2019 Feb 15;11(2):520-528
pubmed: 30899359
Eur J Immunol. 2017 Apr;47(4):607-614
pubmed: 28295238
J Exp Med. 2001 Feb 5;193(3):317-28
pubmed: 11157052
Oncogene. 2016 Apr 21;35(16):2075-86
pubmed: 26234682
Genome Med. 2017 Mar 9;9(1):24
pubmed: 28279190
J Invest Dermatol. 2014 Jul;134(7):1828-1838
pubmed: 24441097
J Allergy Clin Immunol. 2017 Sep;140(3):645-653
pubmed: 28887948
PLoS One. 2011 Apr 04;6(4):e18266
pubmed: 21483750
J Invest Dermatol. 2000 Jan;114(1):135-41
pubmed: 10620129
Dermatology. 2012;225(2):179-82
pubmed: 23095682
Nat Med. 2017 Mar;23(3):337-346
pubmed: 28112734
Nat Protoc. 2013 Dec;8(12):2502-15
pubmed: 24263090
Int J Mol Sci. 2020 Feb 25;21(5):
pubmed: 32106600
Mol Cell Biol. 2013 Jul;33(14):2787-96
pubmed: 23689133
Mol Cell. 2017 Oct 5;68(1):185-197.e6
pubmed: 28943315
Curr Oncol. 2008 Aug;15(4):196-7
pubmed: 18769609
Dev Cell. 2003 Jun;4(6):865-77
pubmed: 12791271
JCI Insight. 2017 Jun 2;2(11):
pubmed: 28570274
Science. 1998 Dec 11;282(5396):2092-5
pubmed: 9851932
J Immunol. 2011 Feb 1;186(3):1495-502
pubmed: 21172868
Nat Rev Dis Primers. 2016 Nov 24;2:16082
pubmed: 27883001
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3422-31
pubmed: 25092341
Int J Mol Sci. 2019 Mar 23;20(6):
pubmed: 30909615
J Immunol. 2009 May 1;182(9):5836-45
pubmed: 19380832
Cell. 2008 Jan 25;132(2):311-22
pubmed: 18243105

Auteurs

Aurore Le (A)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Abdulkader Azouz (A)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Séverine Thomas (S)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Nicolas Istaces (N)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Muriel Nguyen (M)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Stanislas Goriely (S)

Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH